M Lenhard
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Risks and Factors
Papers in
- Oncology 8
- Cancer Risks and Factors 5
-
- Breast Cancer Treatment Studies 3
- Co-authors
- K Friese (3 shared papers)Konstantin Nikolaou (1 shared paper)Sabine Weckbach (1 shared paper)T. Johnson (2 shared papers)Uwe Hasbargen (1 shared paper)Nina Ditsch (8 shared papers)Sibylle Loibl (5 shared papers)Doris Mayr (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)La radiologia medica (1 paper)Cancer Research (1 paper)Geburtshilfe und Frauenheilkunde (2 papers)European Journal of Cancer Supplements (1 paper)
- Partner nations
- GermanyNetherlandsBelgium
In The Last Decade
M Lenhard
14 papers receiving 106 citations
Peers
Comparison fields: 5 of 37
- Cancer Research 19
- Oncology 34
- Hematology 10
- Rheumatology 9
- Equine 1
Countries citing papers authored by M Lenhard
This map shows the geographic impact of M Lenhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Lenhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Lenhard more than expected).
Fields of papers citing papers by M Lenhard
This network shows the impact of papers produced by M Lenhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Lenhard. The network helps show where M Lenhard may publish in the future.
Co-authors
The 25 scholars most cited alongside M Lenhard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 28 | |
| 2 | Retinoid X receptor alpha (RXRα) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in breast cancer: an immunohistochemical study. | 2012 | 19 |
| 3 | 2005 | 14 | |
| 4 | 2010 | 11 | |
| 5 | Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancer. | 2012 | 11 |
| 6 | 2009 | 5 | |
| 7 | 2010 | 5 | |
| 8 | 2011 | 4 | |
| 9 | 2008 | 4 | |
| 10 | 2009 | 2 | |
| 11 | 2007 | 1 | |
| 12 | 2012 | 1 | |
| 13 | 313 Patients with breast cancer during pregnancy – a prospective and retrospective registry (GBG-20 / BIG02-03) | 2010 | 1 |
| 14 | 2006 | 1 | |
| 15 | 2008 | 1 | |
| 16 | 2006 | 0 |
About M Lenhard
M Lenhard is a scholar working on Oncology, Cancer Research, Pediatrics, Perinatology and Child Health, Epidemiology and Genetics, having authored 16 papers that have together received 108 indexed citations. Recurring topics across this work include Cancer Risks and Factors (5 papers), Breast Cancer Treatment Studies (3 papers), Bone fractures and treatments (1 paper), Estrogen and related hormone effects (1 paper), Head and Neck Cancer Studies (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper), BRCA gene mutations in cancer (1 paper) and Ovarian function and disorders (1 paper). The work is most often cited by research in Cancer Research (19 citations), Oncology (34 citations), Hematology (10 citations), Rheumatology (9 citations) and Equine (1 citation). M Lenhard has collaborated with scholars based in Germany, Netherlands and Belgium. Frequent co-authors include K Friese, Konstantin Nikolaou, Sabine Weckbach, T. Johnson, Uwe Hasbargen, Nina Ditsch, Sibylle Loibl, Doris Mayr, Gϋnter von Minckwitz and Antonis Makrigiannakis. Their work appears in journals such as Journal of Clinical Oncology, La radiologia medica, Cancer Research, Geburtshilfe und Frauenheilkunde and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.